Table: Garna Biosciences -9-MTH group results
Nov 7 (Reuters)-
Garna Biosciences Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2016 Sep 30, 2015 Dec 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 581 mln 1.28
(-54.5 pct) (+177.3 pct)
Operating loss 334 mln 584 mln
Recurring loss 352 mln 605 mln
Net loss 178 mln 572 mln
EPS loss 19.52 yen 66.53 yen
EPS Diluted 63.69 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Garna Biosciences Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T
((Tokyo Headline News Desk +813 6441 1812))